Beijing Tong Ren Tang Chinese Medicine Co (HK:3613) has released an update.
Beijing Tong Ren Tang Chinese Medicine Co has entered into a Technical Service Agreement with Tong Ren Tang Technologies to enhance the research and development of essential raw materials for Chinese medicine. This collaboration aims to bolster the company’s production technology and improve product safety, which is expected to increase customer confidence. The agreement, valued at HK$5 million, reflects Tong Ren Tang Technologies’ unique capability to meet the company’s high-tech needs.
For further insights into HK:3613 stock, check out TipRanks’ Stock Analysis page.